Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
1.
Clin Nucl Med ; 48(3): 248-249, 2023 Mar 01.
Article En | MEDLINE | ID: mdl-36723886

ABSTRACT: Lipomatous hypertrophy of the interatrial septum (LHIS) is a benign anomaly with low prevalence. Lipomatous hypertrophy of the interatrial septum is asymptomatic in most of the cases and rarely leads to atrial arrhythmias, obstructive flow symptoms, or sudden death. It is mostly diagnosed as an incidental finding in cross-sectional imaging and echocardiography, and increased 18F-FDG uptake on LHIS has been described. We present a case of repeated increased 18F-PSMA uptake in LHIS. Although very rare, familiarity with the typical features and prevalence of LHIS in PET/CT can avoid misinterpretation for metastatic disease.


Atrial Septum , Heart Neoplasms , Lipoma , Humans , Fluorodeoxyglucose F18 , Heart Septum/pathology , Positron Emission Tomography Computed Tomography , Hypertrophy/diagnostic imaging , Atrial Septum/diagnostic imaging , Atrial Septum/pathology , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/pathology
2.
BMJ Case Rep ; 15(4)2022 Apr 08.
Article En | MEDLINE | ID: mdl-35396243

BRAF V600E mutations are detected in 3%-10% of patients with multiple myeloma (MM) and are associated with more aggressive disease, higher frequency of extramedullary growth and shorter survival. Monotherapy with the BRAF inhibitor vemurafenib has been disappointing in MM. In patients with BRAF-mutated melanoma, MEK and BRAF inhibition has been a successful approach. Here we describe a very good partial response and possible mechanisms of resistance to a combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib in a patient with BRAF V600E-mutant refractory MM.


Multiple Myeloma , Proto-Oncogene Proteins B-raf , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Humans , Imidazoles , Mitogen-Activated Protein Kinase Kinases , Multiple Myeloma/drug therapy , Multiple Myeloma/genetics , Mutation , Oximes , Protein Kinase Inhibitors , Proto-Oncogene Proteins B-raf/genetics , Pyridones , Pyrimidinones
4.
Eur J Nucl Med Mol Imaging ; 42(12): 1883-90, 2015 Nov.
Article En | MEDLINE | ID: mdl-26250690

PURPOSE: To assess the value of SPECT/CT in patients with carpal boss (CB). METHODS: In 24 wrists with CB (18 right-sided, 6 left-sided) in 21 patients, planar images and SPECT/CT images were obtained. Three patients had bilateral CB. The grade of uptake (0 absent, 1 low, 2 moderate, 3 high) on planar imaging and SPECT/CT was assessed and compared with CT findings, clinical symptoms and follow-up findings. RESULTS: CB affected carpometacarpal joint II in 4 wrists, carpometacarpal joint III in 17 wrists and both carpometacarpal joints II and III in 3 wrists. Of the 24 CB, 12 (50 %) were active (i.e. increased radionuclide uptake) on planar images and 18 (75 %) on SPECT/CT images. Of the 17 symptomatic CB, 10 (59 %) were active on planar images and 14 (82 %) were active (mean grade 1.9, range 1 - 3) on SPECT/CT images. Of the 7 asymptomatic CB, 2 were active on planar images and 4 were active (mean grade 1.25, range 1 - 2) on SPECT/CT images. CT alone showed CB in all patients and an accessory ossicle (os styloideum) in 8 wrists. MR imaging was available in 7 patients and positive for CB in 5 (sensitivity 71 %). Plain radiographs were available in 17 patients and positive in 10 (59 %). Therapeutic infiltration of the CB was performed in 9 patients, and resection of the CB in 7 patients. CONCLUSION: SPECT/CT provides important morphological and metabolic information for the clinical assessment of CB, but because SPECT/CT tends to overestimate the clinical importance of CB, we recommend that planar images should still be obtained.


Carpometacarpal Joints/diagnostic imaging , Joint Diseases/diagnostic imaging , Multimodal Imaging , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed , Adolescent , Adult , Female , Follow-Up Studies , Humans , Joint Diseases/therapy , Magnetic Resonance Imaging , Male , Middle Aged , Retrospective Studies , Young Adult
5.
Clin Nucl Med ; 40(9): 744-5, 2015 Sep.
Article En | MEDLINE | ID: mdl-26053721

Besides well-known physiologic uptake of Ga-DOTATATE in spleen, pituitary gland, pancreatic head, adrenals, kidney, and urinary bladder, sometimes unusual areas of uptake are found. We report a case of a 53-year-old woman who had vague pain in abdomen for which abdominal CT was done showing a contrast-enhancing lesion in the pancreatic tail. It was suspected to be of neuroendocrine origin and Ga-DOTATATE PET/CT showed a corresponding focal uptake. Spleen-preserving pancreatic tail resection was performed. Pathology revealed the diagnosis of an accessory intrapancreatic spleen (AIPS).


Neuroendocrine Tumors/diagnostic imaging , Organometallic Compounds , Pancreas/diagnostic imaging , Positron-Emission Tomography , Spleen/diagnostic imaging , Tomography, X-Ray Computed , Female , Humans , Middle Aged , Multimodal Imaging , Pancreas/abnormalities , Radiopharmaceuticals , Spleen/abnormalities
...